ReviewPrimary care diabetes2021
Importance of hyperglycemia in COVID-19 intensive-care patients: Mechanism and treatment strategy.
Review in Primary care diabetes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Covid-19 a Strong Predictor of Hyperglycaemia Among Ugandan Patients: A Retrospective Study.Research square · 2026Article
- The short-term follow-up of patients with diabetes mellitus presenting with COVID-19.Journal of medicine and life · 2025Article
- Postoperative hyperglycemia in patients with traumatic brain injury: development of a prediction model.Archives of medical science : AMS · 2025Article
- Article
- Article
- The complex landscape of intracellular signalling in protein modification under hyperglycaemic stress leading to metabolic disorders.The protein journal · 2024Review
- Older adults' acceptance of the COVID-19 vaccine: Application of the health belief model.Nursing open · 2023Article
- Global burden and drivers of hyperglycemia: Estimates and predictions from 1990 to 2050.Innovation (Cambridge (Mass.)) · 2023Article
- A Retrospective Cohort Analysis of Two Computerized Insulin Infusion Protocols.Journal of diabetes science and technology · 2023Article
- Exploration of Succinimide Derivative as a Multi-Target, Anti-Diabetic Agent: In Vitro and In Vivo Approaches.Molecules (Basel, Switzerland) · 2023Article
- Does the Hyperglycemia Impact on COVID-19 Outcomes Depend upon the Presence of Diabetes?-An Observational Study.Metabolites · 2022Article
- COVID-19 pandemic impact on people with diabetes: results from a large representative sample of Italian older adults.Primary care diabetes · 2022Article
- Article
- Energy intake and weight during the COVID-19 lockdown were not altered in a sample of older adults with type 2 diabetes in England.Diabetes, obesity & metabolism · 2022Article
- Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19.Diabetes care · 2022Observational
- Impact of COVID-19 lockdown on people living with diabetes: Experience from a low-middle income country in South Asia.Primary care diabetes · 2022Article
- COVID-19 vaccines: Current evidence and considerations.Metabolism open · 2021Article
- Prolactin and susceptibility to COVID-19 infection.Medical hypotheses · 2021Article
- Diabetes and COVID-19: Mechanism of pneumonia, treatment strategy and vaccine.Metabolism open · 2021Article
- A Retrospective Study of 268 Patients with SARS-CoV-2 Infection to Evaluate the Association Between Blood Glucose and Severity of COVID-19 Pneumonia and Patient Mortality.Medical science monitor : international medical journal of experimental and clinical research · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review reported that coronavirus disease 2019 (COVID-19) infected patients with short time bed rest or quarantine and airway inflammation are at more risk of developing hyperglycemia and insulin resistance. This condition can induce oxidative stress, decrease immune system function, impair endothelial function, induce apoptosis, and reduce antioxidant in the lungs. We provide a possible mechanism in severe COVID-19 patients and recommend treatment strategy to reduce mortality rate and prevent adverse outcomes after intensive care unit (ICU).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.